• Nenhum resultado encontrado

HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice.

N/A
N/A
Protected

Academic year: 2016

Share "HET0016, a selective inhibitor of 20-HETE synthesis, decreases pro-angiogenic factors and inhibits growth of triple negative breast cancer in mice."

Copied!
20
0
0

Texto

Loading

Referências

Documentos relacionados

Forced expression of miR-7 in aggressive breast cancer cell lines suppressed tumor cell monolayer proliferation, anchorage independent growth, three-dimensional growth in

Conclusion: The angiolymphatic invasion and tumor size proved to be risk factors for death, from all causes, in patients with triple-negative breast cancer.. Differences

In the present study, we identified mutations in exons 9 and 20 of the PIK3CA gene in primary breast tumors from Brazilian breast cancer patients, and we analyzed the

Objective regression in non-small cell lung cancer patients treated in phase I trials of oral ZD 1839 (Iressa), a selective tyrosine kinase inhibitor that blocks the epidermal

O Valor Limite de Exposição (VLE) a um agente químico é uma concentração (no ar do ambiente de trabalho) à qual se considera que praticamente todos os trabalhadores possam

The small number of breast cancer cases exposed to 5ARIs and the lack of an association in our study suggest that the development of breast cancer should not in- fluence

This study evaluated the antitumor activity of esculetin by its effects on cell proliferation and tumor growth in a C57BL/6J mouse xenograft model.. Our data showed that

Expression of two angiogenic factors, vascular endothelial growth factor and platelet-derived endothelial cell growth factor in human pancreatic cancer, and its relationship